Review of Experimental Models of Schizophrenia

References (91)

1. 1 Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans [DOI]
2. 2 Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies [DOI]
3. 3 Neuregulin 1 in neural development, synaptic plasticity and schizophrenia [DOI]
4. 4 Identification of PSD-95 Palmitoylating Enzymes [DOI]
5. 5 Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia [DOI]
6. 6 Phencyclidine animal models of schizophrenia: Approaches from abnormality of glutamatergic neurotransmission and neurodevelopment [DOI]
7. 7 M 4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related central nervous system pathologies [DOI]
8. 8 The neurexin ligands, neuroligins and leucine-rich repeat transmembrane proteins, perform convergent and divergent synaptic functions in vivo [DOI]
9. 9 The possible role of the Akt signaling pathway in schizophrenia [DOI]
10. 10 Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia [DOI]
11. 11 Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats [DOI]
12. 12 Slitrks as emerging candidate genes involved in neuropsychiatric disorders [DOI]
13. 13 Phenotypic Characterization of Transgenic Mice Overexpressing Neuregulin-1 [DOI]
14. 14 Magnesium sulfate reduces inflammation-associated brain injury in fetal mice [DOI]
15. 15 Reelin and its complex involvement in brain development and function [DOI]
16. 16 BDNF–TrkB signaling and neuroprotection in schizophrenia [DOI]
17. 17 Functional Polymorphisms in PRODH Are Associated with Risk and Protection for Schizophrenia and Fronto-Striatal Structure and Function [DOI]
18. 18 Consequences of early life MK-801 administration: Long-term behavioural effects and relevance to schizophrenia research [DOI]
19. 19 Protein kinase Cβ is a modulator of the dopamine D2 autoreceptor‐activated trafficking of the dopamine transporter [DOI]
20. 20 NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia [DOI]
21. 21 Modeling cholinergic aspects of schizophrenia: Focus on the antimuscarinic syndrome [DOI]
22. 22 Behavioral Phenotypes in Schizophrenic Animal Models With Multiple Combinations of Genetic and Environmental Factors [DOI]
23. 23 Intrinsic sensory deprivation induced by neonatal capsaicin treatment induces changes in rat brain and behaviour of possible relevance to schizophrenia [DOI]
24. 24 Inhibition of the l-arginine–nitric oxide pathway mediates the antidepressant effects of ketamine in rats in the forced swimming test [DOI]
25. 25 Preclinical models of antipsychotic drug action [DOI]
26. 26 Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1genes [DOI]
27. 27 Effects of COMT genotype on sensory gating and its modulation by nicotine: Differences in low and high P50 suppressors [DOI]
28. 28 Phencyclidine decreases tickling-induced 50-kHz ultrasound vocalizations in juvenile rats [DOI]
29. 29 Low trihalomethane formation in Korean drinking water [DOI]
30. 30 Two four-marker haplotypes on 7q36.1 region indicate that the potassium channel gene HERG1 (KCNH2, Kv11.1) is related to schizophrenia: a case control study [DOI]
31. 31 Nitric oxide modulates apomorphine-induced recognition memory deficits in rats [DOI]
32. 32 DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis [DOI]
33. 33 Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion [DOI]
34. 34 The Melanin-Concentrating Hormone (MCH) System Modulates Behaviors Associated with Psychiatric Disorders [DOI]
35. 35 Chronic ketamine produces altered distribution of parvalbumin-positive cells in the hippocampus of adult rats [DOI]
36. 36 The spatio-temporal expression of MHC class I molecules during human hippocampal formation development [DOI]
37. 37 The Schizophrenia and Bipolar Disorder associated BRD1 gene is regulated upon chronic restraint stress [DOI]
38. 38 Reversal of scopolamine-induced disruption of prepulse inhibition by clozapine in mice [DOI]
39. 39 Reproducibility of Post-Amphetamine [11C]FLB 457 Binding to Cortical D2/3 Receptors [DOI]
40. 40 Contribution of nonprimate animal models in understanding the etiology of schizophrenia [DOI]
41. 41 Evidence for impaired sound intensity processing during prepulse inhibition of the startle response in a rodent developmental disruption model of schizophrenia [DOI]
42. 42 Differential effects of estrogen and testosterone on auditory sensory gating in rats [DOI]
43. 43 Prepubertal chronic stress and ketamine administration to rats as a neurodevelopmental model of schizophrenia symptomatology [DOI]
44. 44 The ameliorating effects of 5,7-dihydroxy-6-methoxy-2(4-phenoxyphenyl)-4H-chromene-4-one, an oroxylin A derivative, against memory impairment and sensorimotor gating deficit in mice [DOI]
45. 45 Altered netrin‐1 receptor expression in dopamine terminal regions following neonatal ventral hippocampal lesions in the rat [DOI]
46. 46 Association study of bromodomain‐containing 1 gene with schizophrenia in Japanese population [DOI]
47. 47 Short CAG repeats within the hSKCa3 gene associated with schizophrenia [DOI]
48. 48 Opposite effects of neonatal hypoxia on acute amphetamine-induced hyperlocomotion in adult and adolescent mice [DOI]
49. 49 Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.
50. 50 Letter to the Editor: Backbone 1H, 13C and 15N resonance assignments for the 25.8 kDa DNA binding domain of the human p63 protein [DOI]
51. 51 Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia [DOI]
52. 52 Vanilloid (Capsaicin) Receptors and Mechanisms [DOI]
53. 53 The Vanilloid Receptor: A Molecular Gateway to the Pain Pathway [DOI]
54. 54 Maternal Influenza Infection Causes Marked Behavioral and Pharmacological Changes in the Offspring [DOI]
55. 55 Dopaminergic foundations of schizotypy as measured by the German version of the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE)—a suitable endophenotype of schizophrenia [DOI]
56. 56 Genetics of bipolar disorder [DOI]
57. 57 Hypothesis: Is low prenatal vitamin D a risk-modifying factor for schizophrenia? [DOI]
58. 58 Association Between Prenatal Exposure to Bacterial Infection and Risk of Schizophrenia [DOI]
59. 59 An Overview of Animal Models Related to Schizophrenia [DOI]
60. 60 miR-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non–Small Cell Lung Cancer [DOI]
61. 61 Incidental Colonic Focal Lesions Detected by FDG PET/CT [DOI]
62. 62 Effects of maternal immune activation on gene expression patterns in the fetal brain [DOI]
63. 63 Enhanced Carbonyl Stress in a Subpopulation of Schizophrenia [DOI]
64. 64 The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity [DOI]
65. 65 Immature Dentate Gyrus: An Endophenotype of Neuropsychiatric Disorders [DOI]
66. 66 The adhesion protein IgSF9b is coupled to neuroligin 2 via S-SCAM to promote inhibitory synapse development [DOI]
67. 67 Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome [DOI]
68. 68 The Role of the Major Histocompatibility Complex Region in Cognition and Brain Structure: A Schizophrenia GWAS Follow-Up [DOI]
69. 69 Neurobehavioral and Immunological Consequences of Prenatal Immune Activation in Rats. Influence of Antipsychotics [DOI]
70. 70 Differential Effects of Direct and Indirect Dopamine Agonists on Prepulse Inhibition: A Study in D1 and D2 Receptor Knock-Out Mice [DOI]
71. 71 Kynurenine Pathway in Schizophrenia: Pathophysiological and Therapeutic Aspects [DOI]
72. 72 DTNBP1 (Dysbindin) Gene Variants Modulate Prefrontal Brain Function in Healthy Individuals [DOI]
73. 73 Pain insensitivity in the relatives of schizophrenia patients [DOI]
74. 74 The niacin skin flush abnormality in schizophrenia: a quantitative dose–response study [DOI]
75. 75 Dysbindin-Containing Complexes and their Proposed Functions in Brain: From Zero to (too) Many in a Decade [DOI]
76. 76 Nogo Receptor 1 (RTN4R) as a Candidate Gene for Schizophrenia: Analysis Using Human and Mouse Genetic Approaches [DOI]
77. 77 Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex [DOI]
78. 78 A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia [DOI]
79. 79 BDNF and TrkB protein expression is altered in the fetal hippocampus but not cerebellum after chronic prenatal compromise [DOI]
80. 80 A genome-wide supported variant in CACNA1C influences hippocampal activation during episodic memory encoding and retrieval [DOI]
81. 81 Coupling of gene expression in medial prefrontal cortex and nucleus accumbens after neonatal ventral hippocampal lesions accompanies deficits in sensorimotor gating and auditory processing in rats [DOI]
82. 82 Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations [DOI]
83. 83 Complexin 1 knockout mice exhibit marked deficits in social behaviours but appear to be cognitively normal [DOI]
84. 84 Animal models of prenatal immune challenge and their contribution to the study of schizophrenia: a systematic review [DOI]
85. 85 Physiologically based pharmacokinetic model of midazolam disposition during pregnancy [DOI]
86. 86 D-Amphetamine and Antipsychotic Drug Effects on Latent Inhibition in Mice Lacking Dopamine D2 Receptors [DOI]
87. 87 The effects of a DTNBP1 gene variant on attention networks: an fMRI study [DOI]
88. 88 At Issue: The Problem of Obstetrical Complications and Schizophrenia [DOI]
89. 89 CAG‐Repeat length in exon 1 of KCNN3 does not influence risk for schizophrenia or bipolar disorder: A meta‐analysis of association studies [DOI]
90. 90 Effects of AS2586114, a soluble epoxide hydrolase inhibitor, on hyperlocomotion and prepulse inhibition deficits in mice after administration of phencyclidine [DOI]
91. 91 Antidopam inergic effects of leucine and genistein on shizophrenic rat models [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Evaluation of Structural Changes in the Retina of Patients with Schizophrenia — shares topic coverage
• Antipsychotic Drugs Prescription Pattern among Patients with Schizophrenia in a Federal Neuropsychiatric Hospital Maiduguri, North East Nigeria — shares topic coverage
• Perceived Barriers to Help Seeking for Psychosis among Secondary School Students in Lagos, Nigeria — shares topic coverage
• Are Depot Anti-psychotics Associated with Longer Persistence in Treatment Compared with Oral Antipsychotics among Patients with Schizophrenia? — shares topic coverage
• Integrating Cognitive Behaviour Therapy into Schizophrenia Care — shares topic coverage